Schonfeld Strategic Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CRVS Stock Details CRVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$127K	Sell
2024 Q4	$691K	Sell
2024 Q3	$1.75M	Buy